Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F9M82
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,120
Award facts
- Contract value 100% obligated
- $15,119.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $15,119.70 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injector pens under a firm fixed-price contract. The order, issued on December 8, 2025, with a completion date of December 9, 2025, represents a pharmaceutical supply delivery supporting military healthcare needs. Repatha is a PCSK9 inhibitor indicated for cholesterol management in patients with cardiovascular disease, and the SureClick delivery mechanism provides patient-friendly administration. This delivery order was awarded without a set-aside designation through competitive procurement, reflecting AmerisourceBergen's established capability as a major federal pharmaceutical vendor.
This order falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. As the prime contractor for this comprehensive global pharmaceutical support vehicle, AmerisourceBergen supplies a wide range of specialty medications, brand-name and generic drugs, and medical devices to support Defense Health Agency operations and other federal healthcare systems worldwide. The company, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor in the military's pharmaceutical supply chain, leveraging its extensive distribution network to fulfill federal medical procurement requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F9M82?
SPE2DR26F9M82 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 8, 2025.
How much is contract SPE2DR26F9M82 worth?
The government has obligated $15,120 on SPE2DR26F9M82.
Is contract SPE2DR26F9M82 an order under another contract?
Yes. SPE2DR26F9M82 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9M82 competed?
The extent of competition for SPE2DR26F9M82 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award